malondialdehyde has been researched along with isradipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebersole, BJ; Molinoff, PB | 1 |
| Fitscha, P; Gazsó, A; Gludovacz, D; Sinzinger, H; Weiss, K | 1 |
2 other study(ies) available for malondialdehyde and isradipine
| Article | Year |
|---|---|
Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation.
Topics: Animals; Ascorbic Acid; Binding Sites; Brain; Calcium Channel Blockers; Cell Membrane; Culture Techniques; Dihydropyridines; Iron; Isradipine; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Rats; Rats, Inbred Strains | 1991 |
Calcium blockers: antiatherogenic action by influencing the prostaglandin-system.
Topics: Adult; Animals; Arteriosclerosis; Calcium Channel Blockers; Diltiazem; Epoprostenol; Female; Humans; In Vitro Techniques; Isradipine; Male; Malondialdehyde; Nifedipine; Platelet Aggregation; Prostaglandins; Pyridines; Rats; Rats, Inbred Strains; Verapamil | 1989 |